Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Downgrades Albireo Pharma to Neutral

Guggenheim Downgrades Albireo Pharma to Neutral

Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.

January 11, 2023

1 minute read

Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.

Where Remitly Global Stands With Analysts

November 2, 1:00 PM

Within the last quarter, Remitly Global (NASDAQ:RELY) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

November 16, 10:04 AM

Arista Networks (NYSE:ANET) has outperformed the market over the past 5 years by 8.14% on an annualized basis…

April 2, 1:57 PM

Toyota Motor shares dip despite reporting strong March U.S. sales, with electrified vehicles contributing significantly to volume.

November 24, 10:34 AM

Honeywell Intl (NASDAQ:HON) has outperformed the market over the past 10 years by 3.13% on an annualized basis…